Central Pharmaceutical JSC No3
VN:DP3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Central Pharmaceutical JSC No3
Selling, General & Administrative
Central Pharmaceutical JSC No3
Selling, General & Administrative Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Central Pharmaceutical JSC No3
VN:DP3
|
Selling, General & Administrative
-₫113.9B
|
CAGR 3-Years
18%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-4%
|
|
|
H
|
HaTay Pharmaceutical JSC
VN:DHT
|
Selling, General & Administrative
-₫164.3B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-5%
|
|
|
I
|
Imexpharm Corp
VN:IMP
|
Selling, General & Administrative
-₫529.9B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-7%
|
|
|
C
|
Cuu Long Pharmaceutical JSC
VN:DCL
|
Selling, General & Administrative
-₫140.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-2%
|
|
|
D
|
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
|
Selling, General & Administrative
-₫1.6T
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-8%
|
|
|
T
|
Traphaco JSC
VN:TRA
|
Selling, General & Administrative
-₫1.1T
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-6%
|
|
Central Pharmaceutical JSC No3
Glance View
Central Pharmaceutical JSC No.3 engages in the manufacture and sale of pharmaceutical, cosmetic, and nutritious food. The company is headquartered in Haiphong, Hai Phong. The company went IPO on 2015-07-17. The firm's leading products include botanical medicine and other types of drugs, health supplements and cosmetics, among others. Besides, the Company partakes in the commerce of medical equipment and supplies, as well as the conduct of medical research.
See Also
What is Central Pharmaceutical JSC No3's Selling, General & Administrative?
Selling, General & Administrative
-113.9B
VND
Based on the financial report for Dec 31, 2025, Central Pharmaceutical JSC No3's Selling, General & Administrative amounts to -113.9B VND.
What is Central Pharmaceutical JSC No3's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-4%
Over the last year, the Selling, General & Administrative growth was 16%. The average annual Selling, General & Administrative growth rates for Central Pharmaceutical JSC No3 have been 18% over the past three years , 4% over the past five years , and -4% over the past ten years .
